Lung Cancers Recruiting Phase 2 Trials for Nimotuzumab (DB06192)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02428764Neoadjuvant Nimotuzumab Plus Gemcitabine and Carboplatin in Unresectable Stage III Squamous Cell Lung CarcinomaTreatment